← Leaderboards
Haixun Guo
University Of Louisville
$783,607
Attributed
$1,701,348
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $649.5K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,701,348 · 2
By mechanism
R01$1,298,946 · 1
R21$402,402 · 1
Top collaborators
- Jun Yan2 shared
- Nobuyuki Matoba1 shared
- Sucheta Telang1 shared
Most similar at University Of Louisville
Same institution · by research overlap
- Jun Yan$16,605,525
- Robert A. Mitchell$6,052,736
- Sucheta Telang$2,152,673
Others in their field
Other Rising Stars on “Novel Therapeutics”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Angee Greer · Ppd Development Lp$82,531,927
- Suma Babu · Massachusetts General Hospital$26,348,733
- Sabrina Paganoni · Massachusetts General Hospital$26,348,733
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Cynthia M Visness · Rho Federal Systems Division, Inc.$13,531,908
Research focus
Novel TherapeuticsTreatment EfficacyInfiltrationNeoplasm MetastasisResponseSurfaceImmuneImmunotherapyMalignant NeoplasmsMyeloid CellsRadiolabeledAntitumor EffectAnti-Tumor Immune ResponseDiagnosisCancer ModelCancer ImmunotherapyImmunophenotypingImmunotherapeutic AgentCellsCd8-Positive T-LymphocytesMonitorMouse ModelCytometryTumor
Grant awards (3)
Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping$649,473
R01 · FY2025 · CA
Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping$649,473
R01 · FY2024 · CA
Antitumor potential of AvFc lectibody in non-small cell lung cancer$402,402
R21 · FY2023 · CA